Salesforce (NYSE:CRM – Get Free Report) had its target price upped by research analysts at Monness Crespi & Hardt from $200.00 to $222.00 in a research note issued on Thursday. The brokerage currently has a “buy” rating on the CRM provider’s stock. Monness Crespi & Hardt’s price target would indicate a potential upside of 14.91%…
